How Is Quality Control Maintained in Jiangsu UTS Inspection for Research-Grade Peptides?

Quality control in Jiangsu UTS Inspection for research-grade peptides is maintained through a multi-layered system that starts with raw material sourcing and ends with independent third-party verification. Every batch is tested using high-performance liquid chromatography (HPLC) and mass spectrometry (MS) to confirm purity, identity, and concentration. The facility follows Good Manufacturing Practice (GMP) guidelines, and each production run is documented with batch records that are auditable. For example, a typical peptide batch, say a 10 mg vial of a GHRP-2 analog, undergoes a minimum of three separate HPLC runs, with results showing purity consistently above 98.5%—often hitting 99.2% or higher. The lab also uses a validated stability testing protocol, where samples are stored at -20°C, 4°C, and 25°C for 30, 60, and 90 days, then reanalyzed to ensure no degradation occurs. This is not just a checkbox exercise; the data is compiled into a Certificate of Analysis (CoA) that includes the batch number, test date, method references, and raw chromatograms. Researchers can request these CoAs for any lot they purchase, and the information is also published on the company’s internal database for transparency. The inspection process itself is hands-on: technicians visually inspect every vial for cracks, discoloration, or particulate matter before labeling. They also check the lyophilization cake—if it’s collapsed or has a non-uniform texture, the batch is rejected. This level of detail is why labs trust the output from Jiangsu UTS, and it’s a direct reflection of the broader Quality Control in Jiangsu UTS Inspection framework that governs every step from peptide synthesis to final packaging.

Raw Material Verification and Supplier Audits

The first line of defense is raw material verification. Jiangsu UTS Inspection sources amino acids, resins, and coupling reagents from a shortlist of approved suppliers, each of which undergoes an annual on-site audit. In 2023, the facility rejected 12% of incoming raw material lots due to substandard purity—typically below 99.0% for Fmoc-protected amino acids. Each batch of raw material is tested using Fourier-transform infrared spectroscopy (FTIR) and nuclear magnetic resonance (NMR) to confirm the chemical structure. For example, a shipment of Fmoc-Lys(Boc)-OH from a supplier in Zhejiang was flagged because the NMR spectrum showed an extra peak at 1.8 ppm, indicating a residual solvent contamination. That lot was returned, and the supplier was placed on a 90-day probation. The facility also maintains a database of supplier performance metrics, tracking defect rates, delivery times, and corrective action responses. This data is used to score suppliers quarterly, and any supplier with a score below 85 out of 100 is automatically disqualified from new orders. The raw material warehouse is climate-controlled at 20°C ± 2°C with relative humidity below 50%, and all containers are sealed with tamper-evident tape. Once a raw material lot passes verification, it’s assigned a unique identifier that links to its test results, storage location, and usage history. That identifier follows the material through every step of the peptide synthesis process, so any quality issue can be traced back to the exact source.

In-Process Control During Peptide Synthesis

During solid-phase peptide synthesis (SPPS), the quality control team monitors each coupling step in real time. The facility uses a 12-channel automated synthesizer that runs a Kaiser test after every amino acid addition. The Kaiser test, which detects free amines, must show a negative result (clear solution) before the next coupling is initiated. If a positive result (blue color) appears, the coupling is repeated with fresh reagents. In 2024, the facility recorded a 0.8% re-coupling rate across all production runs, which is below the industry average of 2-3%. After synthesis, the peptide is cleaved from the resin using a trifluoroacetic acid (TFA) cocktail, and the crude product is precipitated in cold diethyl ether. The crude peptide is then analyzed by reverse-phase HPLC using a C18 column with a gradient of 0.1% TFA in water and acetonitrile. The target purity for crude material is at least 70%, and if it falls below that, the synthesis parameters are adjusted—typically by extending the coupling time or using a different activator like HATU instead of HBTU. For a typical 50-mer peptide, the crude purity averages 75-80%, which is then purified to >98% using preparative HPLC. The purification process uses a binary gradient system with UV detection at 214 nm and 280 nm. Fractions are collected based on peak thresholds, and only fractions with a purity above 99% are pooled for lyophilization. The entire synthesis and purification process is documented in a batch record that includes time stamps, reagent lot numbers, and operator initials. This record is reviewed by a second QC officer before the batch is released for final processing.

Lyophilization and Final Product Inspection

Lyophilization is a critical step where the peptide is converted from a solution into a stable powder. The facility uses a pilot-scale freeze-dryer with a shelf temperature range of -50°C to +60°C and a condenser temperature of -80°C. The lyophilization cycle is optimized for each peptide based on its thermal properties, which are determined by differential scanning calorimetry (DSC). For example, a peptide with a glass transition temperature (Tg') of -25°C is frozen at -40°C for 2 hours, then primary drying is done at -10°C for 24 hours, followed by secondary drying at 25°C for 6 hours. The final cake must be a uniform, white, and fluffy powder with no collapse or shrinkage. If the cake is cracked or has a glassy appearance, the entire batch is rejected. After lyophilization, the vials are sealed under nitrogen to prevent oxidation, and then each vial is visually inspected under a bright light against a black and white background. The inspection checks for particles, discoloration, and cracks in the glass. In 2023, the facility inspected 15,000 vials and rejected 45 (0.3%) for cosmetic defects. The vials are then labeled with a batch number, peptide name, molecular weight, and storage conditions. A random sample of 10 vials from each batch is sent for final QC testing, which includes HPLC purity, MS confirmation, endotoxin testing (LAL assay), and sterility testing (if applicable). Endotoxin levels must be below 0.5 EU/mg, and sterility is confirmed by incubating samples in tryptic soy broth for 14 days with no growth. The final CoA is generated only after all tests pass, and the batch is then released for packaging and shipping. The entire process, from raw material to final product, takes an average of 14 days for a standard peptide, but rush orders can be completed in 7 days with additional QC checks.

Third-Party Independent Laboratory Testing

Jiangsu UTS Inspection sends every batch to an independent third-party lab for confirmatory testing. The primary lab used is Janoshik, which is accredited to ISO 17025 standards. Each batch is tested for purity, identity, and concentration using HPLC and MS. The lab also performs a stability-indicating assay, where the sample is stressed at 40°C and 75% relative humidity for 7 days, and then reanalyzed to check for degradation products. The results are published on a publicly accessible database, and researchers can verify the CoA by scanning a QR code on the vial label. In 2024, the facility sent 1,200 batches to Janoshik, and the average purity was 99.1% with a standard deviation of 0.4%. The lowest purity recorded was 97.8% for a batch of a long-chain peptide, which was rejected and re-synthesized. The third-party testing also includes a mass confirmation, where the observed molecular weight must match the theoretical value within 0.5 Da. For example, a peptide with a theoretical MW of 1,234.56 Da must show an observed MW between 1,234.06 and 1,235.06 Da. If the mass is off by more than 1 Da, the batch is investigated for truncation or deletion sequences. The lab also checks for residual solvents using gas chromatography (GC), with limits set at 50 ppm for acetonitrile and 100 ppm for ethanol. Any batch exceeding these limits is rejected. The third-party testing is not just a formality; it’s a contractual requirement, and the facility pays for the testing regardless of the outcome. This ensures that the results are unbiased and that the researchers get a true picture of the product quality.

Documentation and Traceability Systems

Every step in the production process is documented in a paperless system that uses barcode scanning and digital signatures. Each vial, reagent bottle, and batch record has a unique barcode that is scanned at every transfer point—from raw material storage to synthesis to final packaging. The system logs the time, date, operator, and location of each scan, creating an audit trail that can be reviewed in real time. If a batch is flagged for a quality issue, the system can trace the problem back to the exact step and operator. For example, in 2023, a batch of a peptide showed a purity drop from 99.2% to 97.5% after lyophilization. The traceability system showed that the lyophilization cycle was interrupted by a power outage, and the shelf temperature rose to -5°C for 30 minutes. That batch was rejected, and the lyophilizer was recalibrated. The system also tracks the storage conditions of each batch, with temperature and humidity sensors that log data every 15 minutes. If the storage temperature exceeds 8°C for more than 30 minutes, an alert is sent to the QC manager. The documentation system is also used to generate the CoA, which includes the batch number, peptide name, molecular weight, purity, MS data, endotoxin results, and storage conditions. The CoA is signed by the QC officer and the production manager, and it’s then uploaded to the facility’s website. Researchers can access the CoA by entering the batch number on the website, and they can also download a PDF copy. The system also tracks the shipping history, so if a customer reports a quality issue, the facility can check the shipping conditions and the time in transit to rule out handling damage. This level of traceability is rare in the industry, and it’s a key reason why researchers choose Jiangsu UTS Inspection over other suppliers.

Continuous Improvement and Staff Training

The quality control team at Jiangsu UTS Inspection undergoes monthly training sessions that cover new testing methods, equipment calibration, and regulatory updates. In 2024, the team completed 24 training hours per person, covering topics like HPLC column maintenance, MS tuning, and GMP documentation. The facility also holds quarterly quality review meetings where the QC team reviews the previous quarter’s data, identifies trends, and implements corrective actions. For example, in Q1 2024, the team noticed that the endotoxin testing failure rate had increased from 0.5% to 1.2%. An investigation revealed that the water used for the LAL assay had a higher than normal bacterial count, so the water purification system was serviced, and the failure rate dropped back to 0.4% in Q2. The facility also participates in proficiency testing programs, where samples are sent to a reference lab and the results are compared. In 2023, the facility’s results for a peptide purity test were within 0.1% of the reference lab’s results, confirming the accuracy of its methods. The continuous improvement program also includes feedback from researchers, who can submit comments through the website or by email. In 2023, the facility received 15 feedback forms, with 12 positive comments about product quality and 3 suggestions for improvement, such as adding more detailed information to the CoA. The facility implemented those suggestions, and now the CoA includes the HPLC column type, gradient conditions, and the MS ionization method. This commitment to continuous improvement ensures that the quality control system stays ahead of industry standards and that researchers get the most reliable peptides possible.